Results 21 to 30 of about 59,458 (179)
A Randomized, Blinded, Placebo-Controlled Crossover Study of the Pharmacokinetics and Pharmacodynamics of Naloxone, Naltrexone, and Nalmefene in Methadone-Sedated Working Dogs. [PDF]
J Vet Pharmacol TherABSTRACT A randomized, blinded, placebo‐controlled crossover study was performed with eight professional working dogs to evaluate the pharmacokinetics and pharmacodynamics of three opioid reversal agents. Following sedation with 1 mg kg−1 methadone HCl IV, dogs were randomly assigned to receive naloxone, naltrexone, or nalmefene at 0.1 mg kg−1 IM, or ...
Mills T +8 more
europepmc +2 more sources
Comparative Safety of Glucagon-Like Peptide 1 Receptor Agonists (GLP-1-RAs) in Type 2 Diabetes and Chronic Weight Management: A Real-World Data Study. [PDF]
Pharmacoepidemiol Drug SafABSTRACT Purpose This study assessed serious clinical outcomes comparing glucagon‐like peptide 1 receptor agonists (GLP‐1‐RAs) with sodium glucose co‐transporter 2 inhibitors (SGLT2‐Is) in patients with type 2 diabetes (T2DM) and patients without diabetes using two chronic weight management (CWM) regimens.
Hurwitz SR +8 more
europepmc +2 more sources
Pain Physician, 2011 Background: Morphine sulfate and naltrexone hydrochloride extended-release capsules (EMBEDA, King Pharmaceuticals, Inc., Bristol, TN), indicated for management of chronic, moderate-to-severe pain, contain pellets of extended-release morphine sulfate with a sequestered naltrexone core (MS-sNT).
Franklin, Johnson, Beatrice, Setnik
+8 more sources
Cirrhosis-induced morphological changes in the retina:possible role of endogenous opioid [PDF]
International Journal of Ophthalmology, 2015 AIM:To investigate the impact of cirrhosis on retinal morphology and to evaluate the role of endogenous opioids as a mediator in cirrhosis induced retinal change.METHODS:Thirty-six male rats were divided into 3 main groups; the common bile duct ligated ...
Mohammad Abdullah Algazo +6 more
doaj +1 more source
Contemporary Clinical Trials Communications, 2021 Opioid-dependence is a comprehensive, relapsing disorder with negative individual, - family, - and societal consequences. Recovery is difficult to achieve.
B.M. Weimand +3 more
doaj +1 more source
International Journal of Electrochemical Science, 2009 Naltrexone is an opioid antagonist, which has been used for treatment of alcoholism and opiate dependence. In this study, the electronic and geometric properties of Naltrexone, sodium tetraphenyl borate and their complexes were studied by computational ...
Mohammad Reza Ganjali +3 more
doaj +1 more source
Phytochemical composition and antinociceptive activity of Bauhinia glauca subsp. hupehana in rats. [PDF]
PLoS ONE, 2015 In traditional medicine, Bauhinia glauca subsp. hupehana has long been used as an analgesic agent in China. The aim of this study was to evaluate the antinociceptive activity of the ethanol extract of the aerial parts of B. glauca subsp.
Jinlong Xu +6 more
doaj +1 more source
Opiate agonists and antagonists modulate taste perception in opiate-maintained, and recently detoxified subjects. [PDF]
, 2013 Heroin addicts consume large quantities of refined sugars. This study investigated the effect of opiate use and antagonism on sweet taste in opiate-maintained drug users and detoxified former chronic opiate users, using a within-subject design.
Green, Amy +14 more
core +1 more source
Night eating syndrome (NES). A case report of NES
European Psychiatry, 2023 Introduction The night eating syndrome (NES, DSM-V: 307.59) was described in 1955 as a disorder defined by morning anorexia, nocturnal hyperphagia (25% of the daily intake of food during sleep) and insomnia. Attributed to a delay in the circadian rhythm
B. Pascual Garcia +2 more
doaj +1 more source
Frontiers in Immunology, 2021 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a debilitating multi-systemic chronic condition of unknown aetiology classified as an immune dysfunction syndrome and neurological disorder.
Helene Cabanas +9 more
doaj +1 more source